Patte, Karen A.
Wade, Terrance J.
MacNeil, Adam J.
Bélanger, Richard E.
Duncan, Markus J.
Riazi, Negin
Leatherdale, Scott T.
Funding for this research was provided by:
Canadian Institutes of Health Research (PJT-149092, PJT-148562)
Institute of Population and Public Health (PJT-180262, MOP-114875)
Sick Kids Foundation (NI21-1193)
Institute of Nutrition, Metabolism and Diabetes (OOP-110788)
Health Canada (#1617-HQ-000012)
Ministère de la Santé et des Services sociaux, Québec, Canada
Direction régionale de santé publique du CIUSSS de la Capitale-Nationale
Article History
Received: 29 June 2022
Accepted: 12 August 2022
First Online: 22 August 2022
Declarations
:
: All procedures received ethics approval from the University of Waterloo Office of Research Ethics (ORE#30118), Brock University Research Ethics Board (REB#18–099), and the CIUSSS de la Capitale-Nationale–Université Laval Research Ethics Board (#MP-13–2017-1264). All procedures were also approved from relevant committees at participating school boards. All guardians provided informed consent and participants provided informed assent using active-information passive-consent parental permission protocols. Using these protocols, parents were informed of the study by schools and could withdraw their child by contacting study staff using the provided contact information. Students not withdrawn from the study by their parents after a two week period or longer after being notified of the study were considered eligible to participate. Under passive-consent protocols, parental informed consent is assumed for all students whose parents that did not contact COMPASS staff to withdraw their child from the study, and this pertained to all participating students. All participating students provided active assent; all eligible students could decline to participate and withdraw from the study at any time. All protocols are carried out in accordance with relevant guidelines and regulations.
: Not applicable.
: None to declare.